Gevo, Inc.
GEVO Nasdaq Industrial Organic Chemicals Financials FY2016โFY2025
Last close ยท Oct 23, 2026
$1.16
1.8%What Gevo, Inc. does
No business description yet.
- Legal name
- Gevo, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K ยท Mar 5, 2026
- Accession ยท CIK
- 0001392380-26-000006
0001392380
Revenue and margins
Gevo, Inc. had $161M of revenue in fiscal 2025, up 849.3% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was โ$43.5M in fiscal 2025, โ27.1% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Gevo, Inc. returned โ to shareholders in fiscal 2025. The diluted share count rose 1.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Gevo, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $316M | $405M | $298M | $189M | $81.2M |
| Debt incl. finance leases | $88.2M | $67.8M | $68.4M | $69.3M | $165M |
| Net debt / EBITDA | โ | โ | โ | โ | 16.5x |
| Debt / equity | 0.1x | 0.1x | 0.1x | 0.1x | 0.4x |
| Interest coverage | โ240.1x | โ88.0x | โ37.9x | โ23.4x | โ1.2x |
| Current ratio | 12.0x | 16.3x | 4.2x | 8.4x | 1.8x |
| Quick ratio | 11.9x | 16.1x | 4.2x | 8.2x | 1.6x |
| Total assets | $645M | $701M | $650M | $584M | $719M |
| Total liabilities | $98.1M | $95.3M | $92.9M | $94.5M | $248M |
| Shareholders' equity | $547M | $605M | $557M | $489M | $466M |
| Net debt (โ = net cash) | โ$228M | โ$337M | โ$230M | โ$120M | $84.3M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. โPlanโ marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
โ
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8โ9 is strong, 0โ2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations is positive | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Return on assets rose | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations exceeds net income | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Debt fell relative to assets | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Current ratio rose | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Share count didn't rise | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Gross margin rose | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Revenue rose relative to assets | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| F-score | โ / 3 | 4 / 8 | 4 / 8 | 1 / 8 | 3 / 9 | 2 / 9 | 4 / 8 | 3 / 8 | 4 / 8 | 3 / 8 |
| Accruals ratio | โ14.9% | โ4.0% | โ12.4% | โ7.8% | โ17.0% | โ2.7% | โ8.0% | โ1.8% | โ3.4% | โ3.1% |
| Altman Z'' | โ10.76 | โ13.37 | โ7.31 | โ13.95 | 18.38 | 5.66 | 6.29 | 4.81 | 1.94 | โ1.40 |
10 years of figures
Amounts in USD. Hover a ratioโs name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $27.2M | $27.5M | $32.9M | $24.5M | $5.5M | $0.7M | $1.2M | $17.2M | $16.9M | $161M |
| Gross profit | โ$9.8M | โ$10.6M | โ$8.7M | โ$12.2M | โ$9.5M | โ$11.5M | โ | โ | โ | โ |
| Research and development | $5.2M | $5.2M | $5.4M | $3.9M | $3.5M | $6.8M | $7.4M | $6.6M | $5.6M | $4.6M |
| Operating income | โ$24.0M | โ$23.3M | โ$22.2M | โ$26.4M | โ$27.0M | โ$60.3M | โ$103M | โ$81.8M | โ$90.8M | โ$20.2M |
| Interest expense | $7.8M | $3.0M | $3.2M | $2.7M | $2.1M | $0.3M | $1.2M | $2.2M | $3.9M | $17.6M |
| Pretax income | โ | โ | โ | โ | โ | โ | โ | โ | โ$78.6M | โ$32.6M |
| Income tax | โ | โ | $0.0M | $0.0M | $0.0M | โ | โ | โ | โ | โ |
| Net income | โ$37.2M | โ$24.6M | โ$28.0M | โ$28.7M | โ$40.2M | โ$59.2M | โ$98.0M | โ$66.2M | โ$78.6M | โ$33.8M |
| Net income to common | โ | โ | โ | โ | โ | โ$59.2M | โ$98.0M | โ$66.2M | โ$78.6M | โ |
| Diluted EPS | โ$193.52 | โ$30.23 | โ$5.74 | โ$2.35 | โ$0.71 | โ$0.30 | โ$0.44 | โ$0.28 | โ$0.34 | โ$0.14 |
| Diluted shares | 0.00B | 0.00B | 0.00B | 0.01B | 0.06B | 0.20B | 0.22B | 0.24B | 0.23B | 0.23B |
| Cash flow | ||||||||||
| Cash from operations | โ$20.5M | โ$20.6M | โ$15.9M | โ$20.8M | โ$19.3M | โ$48.3M | โ$44.3M | โ$53.7M | โ$57.4M | โ$13.4M |
| Capital expenditure | $5.9M | $1.9M | $2.2M | $6.5M | $6.2M | $56.8M | $84.1M | $54.5M | $51.1M | $30.1M |
| Free cash flow | โ$26.5M | โ$22.5M | โ$18.1M | โ$27.3M | โ$25.6M | โ$105M | โ$128M | โ$108M | โ$108M | โ$43.5M |
| Depreciation and amortization | $6.7M | $6.6M | $6.5M | $6.7M | $5.9M | $5.1M | $7.9M | $19.0M | $18.3M | $25.3M |
| Stock-based compensation | $0.9M | $0.4M | $0.7M | $1.3M | $2.1M | $9.9M | $17.4M | $17.1M | $14.7M | $9.2M |
| Acquisitions | โ | โ | โ | โ | โ | โ | โ | โ | $6.1M | โ |
| Share buybacks | โ | โ | โ | โ | โ | โ | โ | โ | $4.7M | โ |
| Dividends and buybacks | โ | โ | โ | โ | โ | โ | โ | โ | $4.7M | โ |
| Balance sheet | ||||||||||
| Cash and short-term investments | $27.9M | $11.6M | $33.7M | $16.3M | $78.3M | $316M | $405M | $298M | $189M | $81.2M |
| Total debt | $35.7M | โ | โ | $0.7M | $1.3M | $67.0M | $67.5M | $68.1M | $67.1M | $165M |
| Finance lease liabilities | โ | โ | โ | โ | $0.2M | $21.2M | $0.3M | $0.2M | $2.2M | $0.7M |
| Current assets | $33.3M | $17.7M | $38.7M | $24.2M | $83.3M | $349M | $415M | $386M | $204M | $143M |
| Current liabilities | $34.7M | $11.2M | $5.3M | $20.1M | $4.9M | $29.1M | $25.4M | $91.4M | $24.4M | $78.6M |
| Inventory | $3.5M | $4.4M | $3.2M | $3.2M | $2.5M | $2.8M | $6.3M | $3.8M | $4.5M | $19.1M |
| Property and equipment, net | $75.6M | $70.4M | $67.5M | $66.7M | $66.4M | $138M | $185M | $212M | $222M | $354M |
| Goodwill | โ | โ | โ | โ | โ | โ | โ | โ | $3.7M | $43.6M |
| Intangible assets | โ | โ | โ | โ | $0.1M | $8.9M | $7.7M | $6.5M | $8.1M | $95.0M |
| Total assets | $112M | $88.9M | $107M | $93.4M | $152M | $645M | $701M | $650M | $584M | $719M |
| Total liabilities | $43.1M | $25.3M | $18.2M | $20.9M | $5.7M | $98.1M | $95.3M | $92.9M | $94.5M | $248M |
| Shareholders' equity | $69.3M | $63.5M | $88.8M | $72.5M | $146M | $547M | $605M | $557M | $489M | $466M |
| Margins | ||||||||||
| Gross margin | โ36.0% | โ38.6% | โ26.5% | โ50.0% | โ171.0% | โ1,611.0% | โ | โ | โ | โ |
| Operating margin | โ88.1% | โ84.6% | โ67.6% | โ107.6% | โ487.0% | โ8,476.5% | โ8,739.2% | โ475.8% | โ536.9% | โ12.6% |
| EBITDA margin | โ63.3% | โ60.4% | โ47.7% | โ80.4% | โ380.4% | โ7,755.3% | โ8,068.0% | โ365.3% | โ428.8% | 3.2% |
| Net margin | โ136.8% | โ89.4% | โ85.1% | โ117.0% | โ725.9% | โ8,326.7% | โ8,341.0% | โ385.0% | โ464.9% | โ21.1% |
| FCF margin | โ97.2% | โ81.8% | โ55.0% | โ111.6% | โ461.6% | โ14,773.7% | โ10,926.6% | โ628.9% | โ641.3% | โ27.1% |
| Returns | ||||||||||
| Return on capital | โ24.6% | โ | โ | โ36.6% | โ30.7% | โ16.0% | โ30.2% | โ19.8% | โ19.5% | โ2.9% |
| Return on capital employed | โ30.9% | โ30.0% | โ21.8% | โ36.0% | โ18.3% | โ9.8% | โ15.2% | โ14.6% | โ16.2% | โ3.2% |
| Return on equity | โ53.7% | โ37.1% | โ36.7% | โ35.5% | โ36.7% | โ17.1% | โ17.0% | โ11.4% | โ15.0% | โ7.1% |
| Return on assets | โ33.1% | โ24.5% | โ28.6% | โ28.6% | โ32.7% | โ14.8% | โ14.6% | โ9.8% | โ12.7% | โ5.2% |
| Return on tangible equity | โ53.7% | โ38.8% | โ31.5% | โ39.5% | โ27.5% | โ11.0% | โ16.4% | โ12.0% | โ16.5% | โ10.3% |
| Growth | ||||||||||
| Revenue growth | โ | 1.2% | 19.3% | โ25.5% | โ77.4% | โ87.2% | 65.3% | 1,363.8% | โ1.7% | 849.3% |
| Share count change | โ | 323.5% | 498.5% | 149.7% | 367.1% | 244.2% | 13.1% | 7.7% | โ2.9% | 1.0% |
| Financial health | ||||||||||
| Net debt / EBITDA | โ | โ | โ | โ | โ | โ | โ | โ | โ | 16.5x |
| Debt / equity | 0.5x | โ | โ | 0.0x | 0.0x | 0.1x | 0.1x | 0.1x | 0.1x | 0.4x |
| Interest coverage | โ3.1x | โ7.9x | โ6.9x | โ9.6x | โ12.9x | โ240.1x | โ88.0x | โ37.9x | โ23.4x | โ1.2x |
| Current ratio | 1.0x | 1.6x | 7.3x | 1.2x | 16.9x | 12.0x | 16.3x | 4.2x | 8.4x | 1.8x |
| Quick ratio | 0.9x | 1.2x | 6.7x | 1.0x | 16.4x | 11.9x | 16.1x | 4.2x | 8.2x | 1.6x |
| Capital allocation | ||||||||||
| Capex / revenue | 21.8% | 6.9% | 6.8% | 26.5% | 112.3% | 7,984.5% | 7,155.5% | 316.6% | 302.0% | 18.8% |
| Stock comp / revenue | 3.3% | 1.5% | 2.1% | 5.5% | 38.4% | 1,388.7% | 1,482.5% | 99.3% | 87.1% | 5.7% |
| Quality scores | ||||||||||
| Piotroski F-score | โ | 4.0 | 4.0 | 1.0 | 3.0 | 2.0 | 4.0 | 3.0 | 4.0 | 3.0 |
| Altman Z'' | โ10.8 | โ13.4 | โ7.3 | โ13.9 | 18.4 | 5.7 | 6.3 | 4.8 | 1.9 | โ1.4 |
| Accruals ratio | โ14.9% | โ4.0% | โ12.4% | โ7.8% | โ17.0% | โ2.7% | โ8.0% | โ1.8% | โ3.4% | โ3.1% |
Source: SEC EDGAR XBRL filings (CIK 0001392380). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only โ not investment advice. Check the original filings before relying on any figure.
